EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Integrating bioinformatics with network pharmacology and experimental validation analysis to reveal the pharmacological mechanism of Ma-xing-shi-gan-tang in treating viral pneumonia

Li Huie, Wang Qiong, An Huijie, Zhang Qiang, Du Wei, Jiao Ying, Pan Siwei, Ding Huihui, Luo Aiwu

Phytomedicine Plus · 2025-08 · 5 (3) · 100837

DOI: 10.1016/j.phyplu.2025.100837 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Phytomedicine Plus, 2025-08. Verfasst von Li Huie und 8 weiteren Autor:innen. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Viral pneumonia is mainly caused by lung inflammation caused by viral infection, and respiratory syncytial virus pneumonia and adenovirus pneumonia are commonly seen in clinical practice. Ma-xing-shi-gan-tang (MXSGT) is a traditional Chinese herbal formula, and many researchers have confirmed its therapeutic effect on viral pneumonia. However, the mechanism of treating viral pneumonia still needs to be elucidated. In this study, network pharmacology has been used to explore the therapeutic effects and therapeutic targets of MXSGT and bioactive compounds. Initially, 143 active proteins and 689 ways of interaction between active proteins were identified through the MXSGT-compound-target and the target protein-protein interaction network. KEGG enrichment analysis revealed 27 signal pathways (P < 0.05), covering the HIF-1α signaling pathway, PI3K-Akt signaling pathway, FoxO signaling pathway, and Toll-like receptor signaling pathway. Through biological experiments, it has been confirmed that compared with the mice of viral pneumonia, the lung index of the MXSGT group is significantly reduced, and the content of inflammatory factors in lung tissue is reduced considerably. MXSGT may exert therapeutic effects on viral pneumonia by inhibiting the PI3K/Akt/HIF-1α pathway.

Zitieren

APA

Huie, L., Qiong, W., Huijie, A., Qiang, Z., Wei, D., Ying, J., Siwei, P., Huihui, D., & Aiwu, L. (2025). Integrating bioinformatics with network pharmacology and experimental validation analysis to reveal the pharmacological mechanism of Ma-xing-shi-gan-tang in treating viral pneumonia. Phytomedicine Plus, 5(3), 100837. https://doi.org/10.1016/j.phyplu.2025.100837

Vancouver

Huie L, Qiong W, Huijie A, Qiang Z, Wei D, Ying J, et al. Integrating bioinformatics with network pharmacology and experimental validation analysis to reveal the pharmacological mechanism of Ma-xing-shi-gan-tang in treating viral pneumonia. Phytomedicine Plus. 2025;5(3):100837. doi:10.1016/j.phyplu.2025.100837

BibTeX
@article{Huie2025,
  author = {Huie, Li and Qiong, Wang and Huijie, An and Qiang, Zhang and Wei, Du and Ying, Jiao and Siwei, Pan and Huihui, Ding and Aiwu, Luo},
  title = {Integrating bioinformatics with network pharmacology and experimental validation analysis to reveal the pharmacological mechanism of Ma-xing-shi-gan-tang in treating viral pneumonia},
  journal = {Phytomedicine Plus},
  year = {2025},
  volume = {5},
  number = {3},
  pages = {100837},
  doi = {10.1016/j.phyplu.2025.100837}
}
Kostenlos starten →